PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0006118|brain tumors |
| Sentences | 1 |
| PubMedID- 23073579 | Unlike colorectal, kidney, lung, and brain tumors, the use of bevacizumab in breast cancer has been, as it were, on a rollercoaster in the united states, from accelerated approval for early drug access by patients in february 2008, to modest efficacy that fell short of high expectations, and increasing concern for serious toxicity in july 2010, and on to fda revocation of accelerated approval for metastatic breast cancer patients in november 2011. |
Page: 1